Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.995 EUR 6.96%
Market Cap: 32.2m EUR
Have any thoughts about
Biosynex SA?
Write Note

Intrinsic Value

The intrinsic value of one ALBIO stock under the Base Case scenario is 7.886 EUR. Compared to the current market price of 2.995 EUR, Biosynex SA is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALBIO Intrinsic Value
7.886 EUR
Undervaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biosynex SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALBIO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALBIO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Biosynex SA

Provide an overview of the primary business activities
of Biosynex SA.

What unique competitive advantages
does Biosynex SA hold over its rivals?

What risks and challenges
does Biosynex SA face in the near future?

Has there been any significant insider trading activity
in Biosynex SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biosynex SA.

Provide P/S
for Biosynex SA.

Provide P/E
for Biosynex SA.

Provide P/OCF
for Biosynex SA.

Provide P/FCFE
for Biosynex SA.

Provide P/B
for Biosynex SA.

Provide EV/S
for Biosynex SA.

Provide EV/GP
for Biosynex SA.

Provide EV/EBITDA
for Biosynex SA.

Provide EV/EBIT
for Biosynex SA.

Provide EV/OCF
for Biosynex SA.

Provide EV/FCFF
for Biosynex SA.

Provide EV/IC
for Biosynex SA.

Show me price targets
for Biosynex SA made by professional analysts.

What are the Revenue projections
for Biosynex SA?

How accurate were the past Revenue estimates
for Biosynex SA?

What are the Net Income projections
for Biosynex SA?

How accurate were the past Net Income estimates
for Biosynex SA?

What are the EPS projections
for Biosynex SA?

How accurate were the past EPS estimates
for Biosynex SA?

What are the EBIT projections
for Biosynex SA?

How accurate were the past EBIT estimates
for Biosynex SA?

Compare the revenue forecasts
for Biosynex SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biosynex SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biosynex SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biosynex SA compared to its peers.

Compare the P/E ratios
of Biosynex SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biosynex SA with its peers.

Analyze the financial leverage
of Biosynex SA compared to its main competitors.

Show all profitability ratios
for Biosynex SA.

Provide ROE
for Biosynex SA.

Provide ROA
for Biosynex SA.

Provide ROIC
for Biosynex SA.

Provide ROCE
for Biosynex SA.

Provide Gross Margin
for Biosynex SA.

Provide Operating Margin
for Biosynex SA.

Provide Net Margin
for Biosynex SA.

Provide FCF Margin
for Biosynex SA.

Show all solvency ratios
for Biosynex SA.

Provide D/E Ratio
for Biosynex SA.

Provide D/A Ratio
for Biosynex SA.

Provide Interest Coverage Ratio
for Biosynex SA.

Provide Altman Z-Score Ratio
for Biosynex SA.

Provide Quick Ratio
for Biosynex SA.

Provide Current Ratio
for Biosynex SA.

Provide Cash Ratio
for Biosynex SA.

What is the historical Revenue growth
over the last 5 years for Biosynex SA?

What is the historical Net Income growth
over the last 5 years for Biosynex SA?

What is the current Free Cash Flow
of Biosynex SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biosynex SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biosynex SA

Current Assets 91.4m
Cash & Short-Term Investments 26.2m
Receivables 21.3m
Other Current Assets 43.9m
Non-Current Assets 150.4m
Long-Term Investments 2.9m
PP&E 16.1m
Intangibles 131.3m
Current Liabilities 51.4m
Accounts Payable 15.1m
Accrued Liabilities 9.7m
Short-Term Debt 239k
Other Current Liabilities 26.4m
Non-Current Liabilities 65.9m
Long-Term Debt 59.6m
Other Non-Current Liabilities 6.3m
Efficiency

Earnings Waterfall
Biosynex SA

Revenue
93m EUR
Cost of Revenue
-43.8m EUR
Gross Profit
49.1m EUR
Operating Expenses
-86.5m EUR
Operating Income
-37.4m EUR
Other Expenses
282k EUR
Net Income
-37.1m EUR

Free Cash Flow Analysis
Biosynex SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALBIO Profitability Score
Profitability Due Diligence

Biosynex SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Positive Gross Profit
Negative Operating Income
46/100
Profitability
Score

Biosynex SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ALBIO Solvency Score
Solvency Due Diligence

Biosynex SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

Biosynex SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALBIO Price Targets Summary
Biosynex SA

Wall Street analysts forecast ALBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALBIO is 12.852 EUR with a low forecast of 12.726 EUR and a high forecast of 13.23 EUR.

Lowest
Price Target
12.726 EUR
325% Upside
Average
Price Target
12.852 EUR
329% Upside
Highest
Price Target
13.23 EUR
342% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALBIO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ALBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALBIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Biosynex SA Logo
Biosynex SA

Country

France

Industry

Health Care

Market Cap

31.3m EUR

Dividend Yield

0%

Description

Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. The company is headquartered in Illkirch-Graffenstaden, Grand Est. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

Contact

GRAND EST
Illkirch-Graffenstaden
22 Boulevard Sebastien Brant
+33388787887
www.biosynex.com

IPO

2011-03-21

Employees

328

Officers

Chairman & CEO
Mr. Larry Abensur
Deputy CEO & Director
Mr. Thomas Lamy

See Also

Discover More
What is the Intrinsic Value of one ALBIO stock?

The intrinsic value of one ALBIO stock under the Base Case scenario is 7.886 EUR.

Is ALBIO stock undervalued or overvalued?

Compared to the current market price of 2.995 EUR, Biosynex SA is Undervalued by 62%.

Back to Top